GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (TSXV:NGEN) » Definitions » Balance Sheet Cash And Cash Equivalents

NervGen Pharma (TSXV:NGEN) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


NervGen Pharma (TSXV:NGEN) Business Description

Industry
Traded in Other Exchanges
Address
2955 Virtual Way, Suite 480, Vancouver, BC, CAN, V5M 4X6
NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.
Executives
John Ruffolo Director